Scientists at Brigham and Women’s Hospital (BWH) have developed a scalable, next-generation platelet bioreactor to generate fully functional human platelets in vitro. The work is a major biomedical advancement that will help address blood transfusion needs worldwide.
The study is published July 21, 2014 in Blood.
“The ability to generate an alternative source of functional human platelets with virtually no disease transmission represents a paradigm shift in how we collect platelets that may allow us meet the growing need for blood transfusions,” said Jonathan Thon, PhD, Division of Hematology, BWH Department of Medicine, lead study author.
According to the researchers, more than 2.17 million platelet units from donors are transfused yearly in the United States to treat patients undergoing chemotherapy, organ transplantation and surgery, as well as for those needing blood transfusions following a major trauma. However, increasing demand; a limited five-day shelf-life; and risk of contamination, rejection and infection have made blood platelet shortages common.
“Bioreactor-derived platelets theoretically have several advantages over conventional, donor-derived platelets in terms of safety and resource utilization,” said William Savage, MD, PhD, medical director, Kraft Family Blood Donor Center at Dana Farber Cancer Institute/Brigham and Women’s Hospital, who did not contribute to the study. “A major factor that has limited our ability to compare bioreactor platelets to donor platelets is the inefficiency of growing platelets, a problem that slows progress of clinical research. This study addresses that gap, while contributing to our understanding of platelet biology at the same time.”
Read more . . .
The Latest on: Platelet bioreactor
[google_news title=”” keyword=”Platelet bioreactor” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Platelet bioreactor
- Platelet Disorderson April 17, 2024 at 5:00 pm
The pathogenesis of suboptimal platelet function is multifactorial. Platelets do not function well if there are too many or too few platelets; also the platelets can be present in the appropriate ...
- Startup SelSym hopes to control bleeding with squishy synthetic plateletson April 15, 2024 at 9:30 pm
Like whole blood for transplants, platelets are perpetually in short supply. But these sticky cell fragments come with an added challenge—while whole blood can be kept for as long as 35 days ...
- Synthetic platelets stanch bleeding, promote healing in animal modelson April 10, 2024 at 5:00 pm
The synthetic platelets are made of hydrogel nanoparticles that mimic the size, shape and mechanical properties of human platelets. Hydrogels are water-based gels that are composed of water and a ...
- Synthetic platelets stanch bleeding, promote healing in animal modelson April 10, 2024 at 5:00 pm
Researchers have developed synthetic platelets that can be used to stop bleeding and enhance healing at the site of an injury. The researchers have demonstrated that the synthetic platelets work ...
- Synthetic platelets stanch bleeding, promote healing in animal modelson April 10, 2024 at 5:00 pm
Synthetic platelets stanch bleeding, promote healing in animal models Date: April 11, 2024 Source: North Carolina State University Summary: Researchers have developed synthetic platelets that can ...
- Impact of lipid emulsions in parenteral nutrition on platelets: a literature reviewon March 25, 2024 at 12:37 pm
The complexity of the formulations of lipid emulsions may lead to adverse outcomes such as platelet reactivity and changes in platelet aggregation and related coagulation. Platelets are responsible ...
- What Is Aplastic Anemia?on March 22, 2024 at 5:00 pm
Sometimes it stops making just one type, but more often you become low on all three: red and white cells, and platelets. It can develop slowly or come on suddenly. If your blood count gets low ...
- Understanding Pregnancy-Induced Thrombocytopeniaon March 21, 2024 at 5:00 pm
People with thrombocytopenia have a low platelet count, which can keep your blood from clotting and increase your chance of dangerous bleeding. Mild thrombocytopenia happens in about 12% of ...
- Platelet-rich plasma does not enhance return to play in hamstring injuries: a randomised controlled trialon July 18, 2023 at 1:35 pm
Background To evaluate the efficacy of a single platelet-rich plasma (PRP) injection in reducing the return to sport duration in male athletes, following an acute hamstring injury. Methods A ...
- Platelets in Hematologic and Cardiovascular Disorderson April 12, 2023 at 10:57 am
Schmidt, Brian M. and Holmes, Crystal M. 2017. Retrospective Cohort Analysis of Pedal Procedures in the Thrombocytopenic Patient. The International Journal of Lower ...
via Bing News